Rituximab in two cases of Goodpasture's syndrome

Mostrar otras versiones (1)

We describe the effects of rituximab in two patients with refractory Goodpasture's syndrome. After one single 1000 mg dose administration, rituximab did not appear to improve renal function in either of our cases. Polyoma virus-negative leukoencephalopathy, a probable toxic side effect of ritux...

Descripción completa

Detalles Bibliográficos
Autores principales: Schless, Birgit, Yildirim, Suzan, Beha, Daniel, Keller, Frieder, Czock, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421183/
https://www.ncbi.nlm.nih.gov/pubmed/25983996
http://dx.doi.org/10.1093/ndtplus/sfp020
_version_ 1782369810798084096
author Schless, Birgit
Yildirim, Suzan
Beha, Daniel
Keller, Frieder
Czock, David
author_facet Schless, Birgit
Yildirim, Suzan
Beha, Daniel
Keller, Frieder
Czock, David
author_sort Schless, Birgit
collection PubMed
description We describe the effects of rituximab in two patients with refractory Goodpasture's syndrome. After one single 1000 mg dose administration, rituximab did not appear to improve renal function in either of our cases. Polyoma virus-negative leukoencephalopathy, a probable toxic side effect of rituximab, was seen in our first patient.
format Online
Article
Text
id pubmed-4421183
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44211832015-05-15 Rituximab in two cases of Goodpasture's syndrome Schless, Birgit Yildirim, Suzan Beha, Daniel Keller, Frieder Czock, David NDT Plus Case Report We describe the effects of rituximab in two patients with refractory Goodpasture's syndrome. After one single 1000 mg dose administration, rituximab did not appear to improve renal function in either of our cases. Polyoma virus-negative leukoencephalopathy, a probable toxic side effect of rituximab, was seen in our first patient. Oxford University Press 2009-06 2009-02-18 /pmc/articles/PMC4421183/ /pubmed/25983996 http://dx.doi.org/10.1093/ndtplus/sfp020 Text en © The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Schless, Birgit
Yildirim, Suzan
Beha, Daniel
Keller, Frieder
Czock, David
Rituximab in two cases of Goodpasture's syndrome
title Rituximab in two cases of Goodpasture's syndrome
title_full Rituximab in two cases of Goodpasture's syndrome
title_fullStr Rituximab in two cases of Goodpasture's syndrome
title_full_unstemmed Rituximab in two cases of Goodpasture's syndrome
title_short Rituximab in two cases of Goodpasture's syndrome
title_sort rituximab in two cases of goodpasture's syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421183/
https://www.ncbi.nlm.nih.gov/pubmed/25983996
http://dx.doi.org/10.1093/ndtplus/sfp020
work_keys_str_mv AT schlessbirgit rituximabintwocasesofgoodpasturessyndrome
AT yildirimsuzan rituximabintwocasesofgoodpasturessyndrome
AT behadaniel rituximabintwocasesofgoodpasturessyndrome
AT kellerfrieder rituximabintwocasesofgoodpasturessyndrome
AT czockdavid rituximabintwocasesofgoodpasturessyndrome

Ejemplares similares